ATRC AtriCure Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRC

Price (delayed)

$26.92

Market cap

$1.36B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$1.29B

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 16
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 54

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
AtriCure's EPS has soared by 88% YoY and by 58% from the previous quarter
ATRC's net income has soared by 88% YoY and by 60% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atricure.com
Peers: TFX EW BSX COO

Key stats

What are the main financial stats of ATRC

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
2.75%
1 week
-4.17%
1 month
-6.46%
1 year
-22.91%
YTD
-31.95%
QTD
-5.64%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$552.16M
Gross profit
$417.46M
Operating income
-$2.97M
Net income
-$4.59M
Gross margin
75.6%
Net margin
-0.8%
The operating margin has surged by 93% year-on-year and by 72% since the previous quarter
The operating income has soared by 92% YoY and by 69% from the previous quarter
The net margin has soared by 90% YoY and by 62% from the previous quarter
ATRC's net income has soared by 88% YoY and by 60% QoQ

Price vs fundamentals

How does ATRC's price correlate with its fundamentals

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
2.73
P/S
2.36
EV/EBIT
507.23
EV/EBITDA
55.41
EV/Sales
2.33
AtriCure's EPS has soared by 88% YoY and by 58% from the previous quarter
ATRC's price to book (P/B) is 40% lower than its 5-year quarterly average of 4.4 and 24% lower than its last 4 quarters average of 3.5
The equity has grown by 8% YoY
ATRC's P/S is 61% below its 5-year quarterly average of 5.8 and 26% below its last 4 quarters average of 3.1
ATRC's revenue is up by 15% year-on-year and by 3.3% since the previous quarter

Efficiency

How efficient is AtriCure business performance
AtriCure's ROS has soared by 163% from the previous quarter and by 108% YoY
The company's return on invested capital has surged by 157% QoQ and by 108% YoY
AtriCure's return on assets has surged by 89% YoY and by 61% QoQ
The ROE has soared by 88% YoY and by 58% from the previous quarter

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
AtriCure's quick ratio has increased by 11% YoY and by 3.5% QoQ
The total liabilities has grown by 11% year-on-year but it has declined by 6% since the previous quarter
The debt is 85% less than the equity
The debt to equity has declined by 12% year-on-year
The equity has grown by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.